4.5 Article

MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer

Journal

EXPERIMENTAL AND MOLECULAR PATHOLOGY
Volume 99, Issue 1, Pages 173-179

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yexmp.2015.06.014

Keywords

MiR-34a; Colorectal cancer; Progression; FMNL2; E2F5

Categories

Funding

  1. National Basic Research Program of China (973 Program) [2015CB554002]
  2. Key project of National Natural Science Fund (Guangdong Province NSFC- joint fund) [U1201226]
  3. National Natural Science Foundation of China [81272759, 81172382, 81472313, 81401927]
  4. Natural Science Foundation of Guangdong Province [S2013010014544]

Ask authors/readers for more resources

Colorectal cancer (CRC) is one of the most common malignancies. Increasing evidences indicate that dysregulation of miRNAs is a frequent event in CRC and contributes to the pathogenesis of CRC. In this study, we found that over-expression of miR-34a inhibited cell proliferation and invasion, induced a cell cycle arrest and triggered apoptosis, while knockdown of miR-34a showed the opposite effects. Moreover, ectopic miR-34a suppressed tumor growth and metastasis of CRC cells in vivo. FMNL2 and E2F5 were identified as direct targets of miR-34a. Reintroduction of FMNL2 or E2F5 without 3'UTR region reversed the inhibitory effects of miR-34a on cell proliferation and invasion. MiR-34a was down-regulated in CRC cells and inversely correlated with FMNL2 and E2F5 expressions. Our study suggests that miR-34a is an important tumor suppressor of CRC progression by targeting FMNL2 and E2F5, thus providing new insight into the molecular mechanisms underlying CRC progression and establishing a strong potential for the application of miR-34a as a novel therapeutic marker against CRC. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available